using SCLC genetically engineered mouse models (GEMM) revealed that MYC activates Notch/REST signaling, prompting the transition of SCLC from an ASCL1+ to a NEUROD1+ and eventually to a YAP1+ state. The gene discussed is YAP1; the disease is small cell lung carcinoma.